REFRACTORY MELANOMA
Clinical trials for REFRACTORY MELANOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MELANOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will take …
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New immune therapy fights tough melanoma
Disease control Recruiting nowThis study tests a new treatment called DOC1021 for people with advanced melanoma that has not responded to standard therapies. The treatment uses a patient's own immune cells, trained to attack their specific tumor. The goal is to see if it is safe and can shrink tumors. About 3…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Diakonos Oncology Corporation • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
Engineered immune cells take on hard-to-treat melanoma in early trial
Disease control Recruiting nowThis early-phase study tests a new type of cell therapy for people with advanced melanoma that has not responded to standard treatments. The therapy uses a patient's own immune cells (NK cells) that have been engineered to recognize and attack a protein called PRAME found on mela…
Matched conditions: REFRACTORY MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:37 UTC